Cite
Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model.
MLA
Mashhouri, Siavash, et al. “Targeting Dectin-1 and or VISTA Enhances Anti-Tumor Immunity in Melanoma but Not Colorectal Cancer Model.” Cellular Oncology (Dordrecht), Apr. 2024. EBSCOhost, https://doi.org/10.1007/s13402-024-00950-w.
APA
Mashhouri, S., Rahmati, A., Azimi, A., Fava, R. A., Ismail, I. H., Walker, J., & Elahi, S. (2024). Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model. Cellular Oncology (Dordrecht). https://doi.org/10.1007/s13402-024-00950-w
Chicago
Mashhouri, Siavash, Amirhossein Rahmati, Ako Azimi, Roy A Fava, Ismail Hassan Ismail, John Walker, and Shokrollah Elahi. 2024. “Targeting Dectin-1 and or VISTA Enhances Anti-Tumor Immunity in Melanoma but Not Colorectal Cancer Model.” Cellular Oncology (Dordrecht), April. doi:10.1007/s13402-024-00950-w.